Cermed Corporation is a medical devices company that has developed an apparatus for advanced diagnostic analysis of cervical tissue, which serves as a routine screening test for women’s cervical cancer. This unique cervical sampling device is able to achieve a 360 degree collection of the entire cervix thereby enhancing the sampling quality and its diagnostic value. This device is poised to replace the traditional Pap smear which is currently used for women’s cervical screening. Advanced techniques for analyzing cervical tissue is critical for the early diagnosis and successful treatment of cervical cancer, the third most common cancer in women.
Categories: cancer, COMPANIES, Diagnostics, Technology Report
